VF
HSTO

Virtu Financial’s Histogen Inc. Common Stock HSTO Stock Holding History

Virtu Financial’s Portfolio HSTO Stock Details HSTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-27,227
Closed -$37K – 2607
2022
Q3 		$37K Buy
+27,227
New +$61.4K ﹤0.01% 1270
2022
Q2 		– Sell
-4,611
Closed -$23K – 2385
2022
Q1 		$23K Sell
4,611
-2,230
-33% -$11.3K ﹤0.01% 1282
2021
Q4 		$46K Buy
6,841
+1,625
+31% +$18.6K ﹤0.01% 1365
2021
Q3 		$79K Buy
5,216
+2,042
+64% +$34.6K 0.01% 1200
2021
Q2 		$69K Buy
+3,174
New +$65.8K 0.01% 1281
2020
Q3 		– Sell
-507
Closed -$39K – 1717
2020
Q2 		$39K Buy
+507
New +$42.5K ﹤0.01% 1043
2019
Q4 		$4K Sell
50
-66
-57% -$4.63K ﹤0.01% 1393
2019
Q3 		$7K Sell
116
-358
-76% -$23.3K ﹤0.01% 1368
2019
Q2 		$25K Buy
+474
New +$82.3K ﹤0.01% 1322
2018
Q4 		– Sell
-129
Closed -$150K – 2123
2018
Q3 		$150K Buy
129
+63
+95% +$58K 0.01% 1134
2018
Q2 		$57K Buy
+66
New +$54.8K ﹤0.01% 1737
2017
Q4 		– Sell
-143
Closed -$157K – 3214
2017
Q3 		$157K Buy
+143
New +$163K 0.01% 1943

Other funds holding HSTO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Virtu Financial's HSTO Position: Q4 2022 in Review

Virtu Financial sold out of Histogen Inc. Common Stock (HSTO) in Q4 2022, closing a stake of 27,227 shares — an estimated $37K sold.

Virtu Financial first reported a position in HSTO in Q3 2017 and held it in 12 quarters. The position peaked at $157K in Q3 2017. 13 funds tracked by Wall St. Rank hold HSTO as of Q4 2022.

  • Virtu Financial reported no remaining Histogen Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Virtu Financial sold 27,227 Histogen Inc. Common Stock shares in Q4 2022, an estimated $37K.
  • Virtu Financial first reported a position in Histogen Inc. Common Stock in Q3 2017 and held it in 12 quarters.
  • Virtu Financial's Histogen Inc. Common Stock position peaked at $157K in Q3 2017.
  • 13 funds tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q4 2022.

Based on Virtu Financial's 13F filing for Q4 2022, filed 15 Feb 2023.